drugset / Trial / NCT03110510
FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study
NaSingle-groupOpen-labelTreatment
Summary
FOLFIRI as a salvage treatment in metastatic biliary tract cancer (BTC) patients who failed gemcitabine containing chemotherapy
Timeline
- Start
- 2019-09-06
- Primary completion
- 2019-09-06
- Completion
- 2019-09-06
Outcome
Outcome not reported
Stopped: “institution problem”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 180 mg/m2 | Intravenous |
| Subject | Leucovorin | Small molecule | 200 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 2400 mg/m2 | — |